QA: Oncotelic Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000908259_2026_Oncotelic_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0000908259, Oncotelic Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,198,252
1 IntangibleAssetsNetIncludingGoodwill 2,788,230
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 389,101,760
4 LiabilitiesCurrent 18,143,278
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 113,213,405
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,995,016
9 ResearchAndDevelopmentExpense 3,729
10 remainder_Expenses 3,809,969
11 remainder_Revenues 0
12 remainder_NetIncome 295,267,155
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 393,088,242
1 Liabilities 131,356,683
2 Expenses 6,808,714
3 Revenues 0
4 StockholdersEquity 261,731,559
5 NetIncome 288,458,441
6 ComprehensiveNetIncome 288,458,441
7 BaseVar 413,260,397
8 EconomicCapitalRatiobeforeLimitedLiability 3.28
9 EconomicCapitalRatio 3.87

Edgar->Model Mapping

Feature Distribution

Change over Time